Netakimab

Netakimab Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:Netakimab
CAS:1796570-08-5
Purity:95% Package:1mg;445USD|5mg;1190USD|10mg;1630USD
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 021-61312847; 18021002903
Email: 3008007409@qq.com
Products Intro: Product Name:Netakimab (anti-IL-17A)
CAS:1796570-08-5
Purity:ExactAb?, Validated, Carrier Free, Low Endotoxin, Azide Free Package:100μg Remarks:K14651
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Netakimab
CAS:1796570-08-5
Purity:95% Package:100ug;500ug;1mg
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Products Intro: Product Name:Netakimab
CAS:1796570-08-5
Purity:95% Package:1mg;1g;100g
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Products Intro: Product Name:Netakimab
Purity:>95%;1mg/ml Package:200ug;500ug;1mg

Netakimab manufacturers

  • Netakimab
  • Netakimab pictures
  • $247.00 / 1mg
  • 2026-01-05
  • CAS:1796570-08-5
  • Min. Order:
  • Purity: 97.57% (SEC-HPLC)
  • Supply Ability: 10g
Netakimab Basic information
Product Name:Netakimab
Synonyms:Netakimab;Research Grade Netakimab(DHH28805);Research Grade Netakimab;Netakimab (anti-IL-17A)
CAS:1796570-08-5
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Netakimab Structure
Netakimab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Netakimab Usage And Synthesis
UsesNetakimab is an anti-IL-17 monoclonal antibody. Nerelimomab can be used for research of ankylosing spondylitis, psoriatic arthritis, moderate-to-severe plaque psoriasis[1][2].
References[1] Puig L, et al. Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial. Dermatol Ther (Heidelb). 2021 Aug;11(4):1319-1332. DOI:10.1007/s13555-021-00554-4
[2] Erdes S, et al. Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults. Clin Exp Rheumatol. 2020 Jan-Feb;38(1):27-34. Epub 2019 Apr 16. PMID:31025924
Netakimab Preparation Products And Raw materials
Tag:Netakimab(1796570-08-5) Related Product Information
Trastuzumab Eldelumab Alemtuzumab Spesolimab Pritumumab Gatralimab Immunoglobulin G 1 (human-mouse monoclonal BIWA4 gamma1-chain antihuman antigen CD44v8), disulfide with human-mouse monoclonal BIWA4 gamma-chain, dimer Dalotuzumab Losatuxizumab Meterelin

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.